Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Indivior
Biotech
6 charged with manipulating stock of 2 biotechs in $41M scheme
The defendants allegedly created fake data and press releases to artificially boost the share prices of Olema Oncology and Opiant Pharmaceuticals.
Darren Incorvaia
Dec 22, 2025 3:08pm
Pfizer’s reputation wrangler plans departure—Chutes & Ladders
Jul 11, 2025 8:30am
Private equity firms take over bluebird's nest—Chutes & Ladders
Feb 28, 2025 8:30am
Aelis' cannabis use drug flops, Indivior rethinks $100M option
Sep 4, 2024 5:04am
Addex stock rises after Indivior offers up to $300M for compound
Aug 27, 2024 10:50am
Click, Indivior to make digital therapeutics for addiction
Sep 8, 2023 1:13pm
